Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
The influence of bisphosphonate therapy on orthodontic movement: a narrative review
PDF (Portuguese (Brazil))

Keywords

Bisphosphonates
Orthodontics
Tooth movement techniques
Bone remodeling
Bone resorption

How to Cite

The influence of bisphosphonate therapy on orthodontic movement: a narrative review. (2022). Electronic Journal Collection Health, 15(4), e10099. https://doi.org/10.25248/reas.e10099.2022

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To carry out a narrative review on the influence of bisphosphonate use on orthodontic movement. Bibliographic review: Bisphosphonates are synthetic drugs similar to pyrophosphate. They are recommended for the control of pathologies that present a high bone resorption. These drugs accumulate in the superficial layer of bone tissue due to their binding by hydroxyapatite, mainly in areas of great bone resorption/remodeling. During bone remodeling, the drug is released at the site, starting its activity on osteoclasts, which reduces its action and cell formation, as well as induces the process of cell death. When osteoclasts arrive, it is known that this is the initial step necessary for the movement provided by orthodontics, and that any complication in the function of these cells will reduce the efficiency and outcome of orthodontic treatment. Final considerations: The use of bisphosphonates is not considered a complete contraindication for orthodontic treatment, especially for patients considered to be at low risk in relation to osteoporosis and neoplasms with bone metastases, however, the treatment outcome is still not predictable in patients with the osteoporosis and neoplasms with high-risk bone metastases.

PDF (Portuguese (Brazil))